These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29730187)

  • 21. Infection regulates pro-resolving mediators that lower antibiotic requirements.
    Chiang N; Fredman G; Bäckhed F; Oh SF; Vickery T; Schmidt BA; Serhan CN
    Nature; 2012 Apr; 484(7395):524-8. PubMed ID: 22538616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
    Norling LV; Spite M; Yang R; Flower RJ; Perretti M; Serhan CN
    J Immunol; 2011 May; 186(10):5543-7. PubMed ID: 21460209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
    Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
    Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation.
    Shinohara M; Serhan CN
    J Atheroscler Thromb; 2016 Jun; 23(6):655-64. PubMed ID: 27052783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory and proresolving lipid mediators.
    Serhan CN; Yacoubian S; Yang R
    Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A; Amabile MI; Monti M; Muscaritoli M
    Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vagus nerve controls resolution and pro-resolving mediators of inflammation.
    Mirakaj V; Dalli J; Granja T; Rosenberger P; Serhan CN
    J Exp Med; 2014 Jun; 211(6):1037-48. PubMed ID: 24863066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.
    Serhan CN; de la Rosa X; Jouvene CC
    J Immunol; 2018 Dec; 201(11):3161-3165. PubMed ID: 30355784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
    Barden A; Shinde S; Phillips M; Beilin L; Mas E; Hodgson JM; Puddey I; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():29-34. PubMed ID: 29789130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
    Norling LV; Ly L; Dalli J
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.
    Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.
    Tao X; Lee MS; Donnelly CR; Ji RR
    Neurotherapeutics; 2020 Jul; 17(3):886-899. PubMed ID: 32696274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
    Mas E; Barden A; Burke V; Beilin LJ; Watts GF; Huang RC; Puddey IB; Irish AB; Mori TA
    Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid mediators in the resolution of inflammation.
    Serhan CN; Chiang N; Dalli J; Levy BD
    Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.